2025-05-20 2025-05-20 , online online, 1,290 € plus tax Dr. Florian Csintalan https://www.forum-institut.com/seminar/25092002-global-value-demonstration-market-access-pricing/referenten/25/25_09/25092002-global-value-demonstration,-market-access-pricing_csintalan-florian.jpg Global Value Demonstration, Market Access & Pricing

You will gain actionable insights into global market access strategies, payer evidence requirements, and health economic tools - enabling you to support strategic decision-making across diverse healthcare systems.

Topics
  • Evidence Demonstration & HTA
  • Value Proposition and Communication
  • Commercial Models for Market Access
  • Health economic modeling and evaluations
  • Global Market Access Strategy


Who should attend
This course is designed for professionals working in Market Access, Pricing, and HEOR, as well as business development and commercial affairs managers who are involved in shaping or executing global access strategies.
Aims and objectives
This compact seminar offers a comprehensive overview of commercial models, pricing strategies, and market access pathways within the global healthcare environment.

Participants will explore essential aspects such as licensing models, payer evidence generation, value-based healthcare systems, and health technology assessments. Through expert-led sessions and practical case discussions, the course enables participants to critically assess value propositions, apply health economic tools, and understand pricing frameworks. Special focus will be placed on the integration of real-world evidence, global and local HTA synergies, and communication strategies tailored to payer expectations.

By the end of the seminar, participants will be equipped to support the design of a robust international market access strategy.
Your benefit

  • Get practical insights into global commercial and licensing models - from classical sales to managed entry agreements
  • Understand how payer evidence requirements and HTA systems differ across healthcare markets and how to manage them effectively
  • Learn to develop and communicate strong payer value propositions aligned with value-based care principles.
  • Gain hands-on experience with health economic modelling tools such as budget impact, cost-effectiveness, and real-world evidence integration

25092002 Seminar Global Value Demonstration, Market Access & Pricing

Global Value Demonstration, Market Access & Pricing

Benefits
  • Payer Evidence Requirements and HTA systems
  • Health Economic Modelling Tools
  • Pricing Methodologies
  • Officially certified to ISO 9001 and ISO 21001 standards

Webcode 25092002

Book now

JETZT Buchen

Speakers


Everything at a glance

Appointment

29/09/2025

29/09/2025

Period

9:00 am - 5:00 pm online seminar
You may dial in 30 minutes in advance

9:00 am - 5:00 pm online seminar
You may dial in 30 minutes in advance
Venue

online

online

Fee
Your contact

Dr. Henriette Wolf-Klein
Head of Department

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

You will gain actionable insights into global market access strategies, payer evidence requirements, and health economic tools - enabling you to support strategic decision-making across diverse healthcare systems.

Topics

  • Evidence Demonstration & HTA
  • Value Proposition and Communication
  • Commercial Models for Market Access
  • Health economic modeling and evaluations
  • Global Market Access Strategy


Who should attend
This course is designed for professionals working in Market Access, Pricing, and HEOR, as well as business development and commercial affairs managers who are involved in shaping or executing global access strategies.

Aims and objectives

This compact seminar offers a comprehensive overview of commercial models, pricing strategies, and market access pathways within the global healthcare environment.

Participants will explore essential aspects such as licensing models, payer evidence generation, value-based healthcare systems, and health technology assessments. Through expert-led sessions and practical case discussions, the course enables participants to critically assess value propositions, apply health economic tools, and understand pricing frameworks. Special focus will be placed on the integration of real-world evidence, global and local HTA synergies, and communication strategies tailored to payer expectations.

By the end of the seminar, participants will be equipped to support the design of a robust international market access strategy.

Your benefit

  • Get practical insights into global commercial and licensing models - from classical sales to managed entry agreements
  • Understand how payer evidence requirements and HTA systems differ across healthcare markets and how to manage them effectively
  • Learn to develop and communicate strong payer value propositions aligned with value-based care principles.
  • Gain hands-on experience with health economic modelling tools such as budget impact, cost-effectiveness, and real-world evidence integration

Detailed programme

9:00 am - 5:00 pm online seminar
You may dial in 30 minutes in advance

09:00 Welcome and introduction


09:15

Dr. Vanessa Elisabeth Schaub

How to develop a global market access strategy
  • Why is market access and pricing so important?
  • What does a successful pricing and market access strategy look like?
    • market landscape considerations
    • value of the product
    • willingness to payInternational considerations (international reference pricing, parallel trade)
  • Case study

10:15 Short break


10:30

Pietro Sternini

HEOR in practice
  • Health economic modeling: budget impact, cost-effectiveness, cost-utility models
  • Health economic evaluations
  • Integration of real-world-evidence and patient oriented outcomes

11:30 Short break


11:40

Dr. Florian Csintalan

Evidence demonstration & Health technology assessment
  • Payer evidence vs. marketing authorisation requirements
  • How to deal with differing HTA requirements - How to identify global and local synergies

12:30 Lunch break


13:45

Dr. Florian Csintalan

Value proposition and communication
  • Value proposition models
  • Payer Value Proposition

14:30 Coffee break


15:00

Dr. Vanessa Elisabeth Schaub

Global access trends and challenges
  • EU JCA
  • Global health care reforms and changes
  • Inflation reduction act (IRA) in the US and further developments

15:50 Short break


16:00

Pietro Sternini

Commercial models for the market access
  • Classical sales model
  • Licensing models - which regions? Which business model?
  • Further options: Managed entry agreements...

17:00 Seminar end


Further information

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

This distinguishes our events

of 5 stars of all ratings from 2024

of 5 stars on Trustpilot = good

Recommendations

Strategic Market Access in Europe: From HTA to Pricing Negotiations

This online seminar provides a comprehensive introduction to drug market access and pricing strategies in five key Europ...

09. - 10.12.2025 in
Details

Patient Involvement in HTA

This course offers a deep dive into patient involvement in HTA processes across Europe, with a focus on the UK and Germa...

10.09.2025 in
Details

Leveraging AI in Evidence Generation and Market Access

Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...

10.07.2025 in
Details

AMNOG and the EU HTA - Insights into the German Market

This seminar will focus on AMNOG and JCA dossier preparation as well as the German AMNOG procedure in comparison with th...

23.09.2025 in
Details

Go forward

List of abbreviations pharma & healthcare

Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.

Details
Abbreviations, Glossary
Testimonials

Hear from our past delegates and sponsors and learn more about the events.

Details
Testimonials
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality